- Home
- DENN vs TIL Comparison
DENN vs TIL Comparison
Compare DENN & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- TIL
- Stock Information
- Founded
- DENN 1953
- TIL 2018
- Country
- DENN United States
- TIL United States
- Employees
- DENN N/A
- TIL N/A
- Industry
- DENN Restaurants
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- DENN Consumer Discretionary
- TIL Health Care
- Exchange
- DENN Nasdaq
- TIL Nasdaq
- Market Cap
- DENN 203.4M
- TIL 171.7M
- IPO Year
- DENN 1989
- TIL 2021
- Fundamental
- Price
- DENN $3.34
- TIL $13.05
- Analyst Decision
- DENN Strong Buy
- TIL Buy
- Analyst Count
- DENN 6
- TIL 5
- Target Price
- DENN $7.75
- TIL $114.00
- AVG Volume (30 Days)
- DENN 1.5M
- TIL 80.2K
- Earning Date
- DENN 04-29-2025
- TIL 05-09-2025
- Dividend Yield
- DENN N/A
- TIL N/A
- EPS Growth
- DENN 17.14
- TIL N/A
- EPS
- DENN 0.41
- TIL N/A
- Revenue
- DENN $452,334,000.00
- TIL N/A
- Revenue This Year
- DENN $5.81
- TIL N/A
- Revenue Next Year
- DENN $2.50
- TIL N/A
- P/E Ratio
- DENN $8.37
- TIL N/A
- Revenue Growth
- DENN N/A
- TIL N/A
- 52 Week Low
- DENN $3.16
- TIL $9.62
- 52 Week High
- DENN $8.83
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- DENN 28.70
- TIL 36.69
- Support Level
- DENN $3.61
- TIL $16.51
- Resistance Level
- DENN $3.84
- TIL $18.92
- Average True Range (ATR)
- DENN 0.19
- TIL 1.71
- MACD
- DENN 0.02
- TIL -0.27
- Stochastic Oscillator
- DENN 28.42
- TIL 3.48
Stock Price Comparison Chart: DENN vs TIL
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.